Tapewire

OTC · USD

ZVSA

ZyVersa Therapeutics, Inc.

Export transactions ↓
Tapewire entity
8639
SEC CIK
0001859007
Parsed reports
51

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2022 Filed Dec 15, 2022 00:37 UTC
Wolfe PeterChief Financial Officer
GrantStock Options (right to buy) · Derivative 39,708 $0.00 Strike: $11.58 $0.00
Disclosure

SEC source: 0001493152-22-035487 · ownership.xml · derivative · entry 4

Wolfe Peter · CIK 0001954398 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,708

Underlying: Common Stock · 39,708 shares

Expires 2029-04-02

F4 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:37 UTC
Wolfe PeterChief Financial Officer
GrantStock Options (right to buy) · Derivative 9,927 $0.00 Strike: $5.09 $0.00
Disclosure

SEC source: 0001493152-22-035487 · ownership.xml · derivative · entry 3

Wolfe Peter · CIK 0001954398 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,927

Underlying: Common Stock · 9,927 shares

Expires 2027-10-30

F3 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 4 equal annual installments commencing on October 30, 2017.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:37 UTC
Wolfe PeterChief Financial Officer
GrantStock Options (right to buy) · Derivative 9,927 $0.00 Strike: $5.09 $0.00
Disclosure

SEC source: 0001493152-22-035487 · ownership.xml · derivative · entry 2

Wolfe Peter · CIK 0001954398 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,927

Underlying: Common Stock · 9,927 shares

Expires 2025-10-21

F2 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on October 21, 2016.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:37 UTC
Wolfe PeterChief Financial Officer
GrantCommon Stock 41,585 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-22-035487 · ownership.xml · nonDerivative · entry 1

Wolfe Peter · CIK 0001954398 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,585

F1 · price: Received in connection with the Issuer's business combination with Larkspur Health Acquisition Corp., a Delaware corporation ("Larkspur") in accordance with the terms of the Business Combination Agreement, dated July 20, 2022, as amended (the "Business Combination Agreement") by and among ZyVersa Therapeutics, Inc., a Florida corporation ("Old ZyVersa"), the Securityholder Representative (as defined in the Business Combination Agreement) named therein, Larkspur, and Larkspur Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Larkspur ("Merger Sub") pursuant to which Merger Sub merged with and into Old ZyVersa (the "Acquisition Merger"), with Old Zyversa as the surviving company of the Acquisition Merger and, after giving effecting to such Acquisition Merger, Old ZyVersa became a wholly-owned subsidiary of Larkspur and changed its name to the Issuer.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:34 UTC GrantStock Options (right to buy) · Derivative 9,927 $0.00 Strike: $16.36 $0.00
Disclosure

SEC source: 0001493152-22-035485 · ownership.xml · derivative · entry 2

Park Min-Chul · CIK 0001956022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,927

Underlying: Common Stock · 9,927 shares

Expires 2032-01-28

F2 · derivative.exercise_date: The option vests in 3 equal annual installments commencing on January 28, 2023.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:34 UTC GrantStock Options (right to buy) · Derivative 29,781 $0.00 Strike: $16.36 $0.00
Disclosure

SEC source: 0001493152-22-035485 · ownership.xml · derivative · entry 1

Park Min-Chul · CIK 0001956022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,781

Underlying: Common Stock · 29,781 shares

Expires 2031-07-01

F1 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested on July 1, 2021.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:27 UTC
Cashmere Karen A.Chief Commercial Officer
GrantStock Options (right to buy) · Derivative 21,840 $0.00 Strike: $16.36 $0.00
Disclosure

SEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 5

Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,840

Underlying: Common Stock · 21,840 shares

Expires 2032-01-28

F5 · derivative.exercise_date: The option vests in 3 equal annual installments commencing on January 28, 2023.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:27 UTC
Cashmere Karen A.Chief Commercial Officer
GrantStock Options (right to buy) · Derivative 21,840 $0.00 Strike: $16.36 $0.00
Disclosure

SEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 4

Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,840

Underlying: Common Stock · 21,840 shares

Expires 2031-02-08

F4 · derivative.exercise_date: The option vests in 3 equal annual installments commencing on February 8, 2022.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:27 UTC
Cashmere Karen A.Chief Commercial Officer
GrantStock Options (right to buy) · Derivative 29,781 $0.00 Strike: $11.58 $0.00
Disclosure

SEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 3

Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,781

Underlying: Common Stock · 29,781 shares

Expires 2029-04-02

F3 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:27 UTC
Cashmere Karen A.Chief Commercial Officer
GrantStock Options (right to buy) · Derivative 19,854 $0.00 Strike: $5.03 $0.00
Disclosure

SEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 2

Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,854

Underlying: Common Stock · 19,854 shares

Expires 2027-10-30

F2 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 4 equal annual installments commencing on October 30, 2017.

Read SEC document
December 12, 2022 Filed Dec 15, 2022 00:27 UTC
Cashmere Karen A.Chief Commercial Officer
GrantStock Options (right to buy) · Derivative 9,927 $0.00 Strike: $5.03 $0.00
Disclosure

SEC source: 0001493152-22-035481 · ownership.xml · derivative · entry 1

Cashmere Karen A. · CIK 0001954546 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,927

Underlying: Common Stock · 9,927 shares

Expires 2024-09-10

F1 · derivative.exercise_date: 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on September 10, 2014.

Read SEC document
December 12, 2022 Filed Dec 16, 2022 21:41 UTC GrantWarrant (right to buy) · Derivative 450,702 $0.00 Strike: $6.90 $0.00
Disclosure

SEC source: 0001493152-22-035808 · ownership.xml · derivative · entry 2

INCON Co., Ltd. · CIK 0001958829 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,702

Underlying: Common Stock · 450,702 shares

Expires 2027-12-12

F1 · derivative.exercise_date: The warrant is immediately exercisable in full.

Read SEC document
December 12, 2022 Filed Dec 16, 2022 21:41 UTC GrantCommon Stock 1,497,199 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-035808 · ownership.xml · nonDerivative · entry 1

INCON Co., Ltd. · CIK 0001958829 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,497,199

Read SEC document
March 08, 2022 Filed Mar 8, 2022 13:51 UTC OtherClass B Common Stock 3,427 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-016941 · doc4.xml · nonDerivative · entry 1

A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 446,843

F1 · kind: Transfer of shares to certain investors for no consideration as contemplated in connection with Issuer's initial public offering because underwriters' over-allotment option was not fully exercised.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 19:36 UTC OtherClass B Common Stock 49,730 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007614 · doc4.xml · nonDerivative · entry 1

A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. · CIK 0000318492 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,270

F1 · kind: Cancellation of 49,730 shares ("Shares") of Issuer's Class B common stock as contemplated in connection with Issuer's initial public offering. Such Shares were forfeited and cancelled for no consideration because underwriters' over-allotment option was not fully exercised.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 17:30 UTC OtherClass B common stock · Derivative 953 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011642 · ownership.xml · derivative · entry 1

Skalicky Gregory · CIK 0001878571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,631

Underlying: Class A common stock · 953 shares

Expires not disclosed

F1 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F1 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · kind: As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement.

F1 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F1 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

Read SEC document
January 06, 2022 Filed Mar 10, 2022 17:30 UTC OtherClass B common stock · Derivative 953 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011643 · ownership.xml · derivative · entry 1

Twitty Christopher · CIK 0001870121 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,631

Underlying: Class A common stock · 953 shares

Expires not disclosed

F1 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F1 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · kind: As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement.

F1 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F1 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

Read SEC document
January 06, 2022 Filed Mar 10, 2022 22:31 UTC
O'Connor Daniel J.Director · Chief Executive Officer
OtherClass B common stock · Derivative 609 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011644 · ownership.xml · derivative · entry 3

O'Connor Daniel J. · CIK 0001376847 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 201,848

Underlying: Class A common stock · 609 shares

Expires not disclosed

F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F5 · shares: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the Sponsor for no consideration.

F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · ownership.direct: The shares represent those owned by Mr. O'Connor, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 22:31 UTC
O'Connor Daniel J.Director · Chief Executive Officer
OtherClass B common stock · Derivative 23,404 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011644 · ownership.xml · derivative · entry 2

O'Connor Daniel J. · CIK 0001376847 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 201,239

Underlying: Class A common stock · 23,404 shares

Expires not disclosed

F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F4 · shares: As contemplated in connection with the initial public offering of the Issuer, 22,343 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement.

F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · ownership.direct: The shares represent those owned by Mr. O'Connor, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 22:31 UTC
O'Connor Daniel J.Director · Chief Executive Officer
OtherClass A Common Stock 42,005 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011644 · ownership.xml · nonDerivative · entry 1

O'Connor Daniel J. · CIK 0001376847 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 42,005

F1 · security: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.

F1 · kind: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.

F2 · ownership.nature: The shares represent those owned by Mr. O'Connor, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 17:30 UTC
Briones David S.Director · Chief Financial Officer
OtherClass B common stock · Derivative 91 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011641 · ownership.xml · derivative · entry 3

Briones David S. · CIK 0001599831 · Director · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 56,123

Underlying: Class A common stock · 156 shares

Expires not disclosed

F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F5 · shares: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the Sponsor for no consideration.

F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · ownership.direct: The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 17:30 UTC
Briones David S.Director · Chief Financial Officer
OtherClass B common stock · Derivative 1,533 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011641 · ownership.xml · derivative · entry 2

Briones David S. · CIK 0001599831 · Director · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 55,967

Underlying: Class A common stock · 1,533 shares

Expires not disclosed

F3 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · kind: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F4 · shares: As contemplated in connection with the initial public offering of the Issuer, 22,343 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement.

F3 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · ownership.direct: The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 17:30 UTC
Briones David S.Director · Chief Financial Officer
OtherClass A Common Stock 10,752 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011641 · ownership.xml · nonDerivative · entry 1

Briones David S. · CIK 0001599831 · Director · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 10,752

F1 · security: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.

F1 · kind: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Larkspur Health LLC (the "Sponsor") in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.

F2 · ownership.nature: The shares represent those owned by Mr. Briones, a member of Larkspur Health LLC based on his pro rata share of ownership of Larkspur Health LLC.

Read SEC document
January 06, 2022 Filed Mar 10, 2022 17:32 UTC
Mehra RajDirector
OtherClass B common stock · Derivative 953 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011645 · ownership.xml · derivative · entry 1

Mehra Raj · CIK 0001757892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,631

Underlying: Class A common stock · 953 shares

Expires not disclosed

F1 · security: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F1 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · kind: As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement.

F1 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F1 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

Read SEC document
January 06, 2022 Filed Mar 10, 2022 22:32 UTC OtherClass B Common Stock · Derivative 3,427 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011646 · ownership.xml · derivative · entry 2

Larkspur Health LLC · CIK 0001915818 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,141,326

Underlying: Class A Common Stock · 3,427 shares

Expires not disclosed

F2 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F3 · kind: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration.

F3 · shares: In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration.

F2 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

F2 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the "Registration Statement") under the section entitled "Description of Securities - Founder Shares," the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date

Read SEC document
January 06, 2022 Filed Mar 10, 2022 22:32 UTC OtherClass A Common Stock 236,273 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-011646 · ownership.xml · nonDerivative · entry 1

Larkspur Health LLC · CIK 0001915818 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,273

F1 · kind: These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Reporting Person in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.